Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of plasma-derived factor VIII concentrate (Thai Red Cross)
TCTR20170228002Phase 3Enrolling by invitation
- Sponsor
- Thai Society of Hematology
- Start
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Factor VIII in hemophilia A, sponsored by Thai Society of Hematology. Started Mar 2017; status: enrolling by invitation.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on TCTR20170228002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170228002.